Sign Up
OverviewAPI
The global oncology drugs market is poised for substantial growth, projected to reach $474.06 billion by 2030 with a CAGR of 11.53%. Key drivers include increased cancer cases, treatment advancements, and rising tobacco use. Major pharmaceutical companies are heavily investing in R&D and engaging in strategic mergers and acquisitions. Targeted therapy and injectables lead the market, with North America at the forefront due to high cancer rates and advanced healthcare systems.

Ask a question